Akthelia Pharmaceuticals
Late preclinical-stage immunotherapy biopharma company, with a breakthrough strategy to up-regulate the innate immunology of epithelia.
Akthelia Pharmaceuticals is a company in biotechnology, medical, pharmaceutical based in Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 2001.
As a business in biotechnology, medical, pharmaceutical, Akthelia Pharmaceuticals is listed here with the public details available about it.
Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) is where the company is located.
Its current recorded stage is Grant.
The company reports a headcount in the c_00001_00010 range.
Public records show total funding of about $64M.
| Sector | Biotechnology, Medical, Pharmaceutical |
|---|---|
| Headquarters | Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2001 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $64,000,000 |
Website: www.aktheliapharma.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account